Begenik, H. Et Al. 2013. Serum malondialdehyde levels, myeloperoxidase and catalase activities in patients with nephrotic syndrome. REDOX REPORT , vol.18, no.3 , 107-112.

Begenik, H., Soyoral, Y. U., Erkoc, R., Emre, H., TAŞKIN, A., Tasdemir, M., ... Aslan, M.(2013). Serum malondialdehyde levels, myeloperoxidase and catalase activities in patients with nephrotic syndrome. REDOX REPORT , vol.18, no.3, 107-112.

Begenik, Hüseyin Et Al. "Serum malondialdehyde levels, myeloperoxidase and catalase activities in patients with nephrotic syndrome," REDOX REPORT , vol.18, no.3, 107-112, 2013

Begenik, Hüseyin Et Al. "Serum malondialdehyde levels, myeloperoxidase and catalase activities in patients with nephrotic syndrome." REDOX REPORT , vol.18, no.3, pp.107-112, 2013

Begenik, H. Et Al. (2013) . "Serum malondialdehyde levels, myeloperoxidase and catalase activities in patients with nephrotic syndrome." REDOX REPORT , vol.18, no.3, pp.107-112.

@article{article, author={Hüseyin Beğenik Et Al. }, title={Serum malondialdehyde levels, myeloperoxidase and catalase activities in patients with nephrotic syndrome}, journal={REDOX REPORT}, year=2013, pages={107-112} }